Open AccessPlasma amyloid beta levels are associated with cerebral amyloid and tau deposition
Author(s) -
Risacher Shan L.,
Fandos Noelia,
Romero Judith,
Sherriff Ian,
Pesini Pedro,
Saykin Andrew J.,
Apostolova Liana G.
Publication year - 2019
Publication title -
alzheimer's and dementia: diagnosis, assessment and disease monitoring
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.497
H-Index - 37
ISSN - 2352-8729
DOI - 10.1016/j.dadm.2019.05.007
Subject(s) - cognitive impairment , positron emission tomography , amyloid beta , amyloid (mycology) , alzheimer's disease , voxel , beta (programming language) , β amyloid , medicine , nuclear medicine , pathology , cardiology , psychology , disease , radiology , computer science , programming language
We investigated the relationship of plasma amyloid beta (Aβ) with cerebral deposition of Aβ and tau on positron emission tomography (PET). Methods Forty‐four participants (18 cognitively normal older adults [CN], 10 mild cognitive impairment, 16 Alzheimer's disease [AD]) underwent amyloid PET and a blood draw. Free and total plasma Aβ40 and Aβ42 were assessed using a validated assay. Thirty‐seven participants (17 CN, 8 mild cognitive impairment, 12 AD) also underwent a [ 18 F]flortaucipir scan. Scans were preprocessed by standard techniques, and mean global and regional amyloid and tau values were extracted. Free Aβ42/Aβ40 (Aβ F42:F40) and total Aβ42/Aβ40 (Aβ T42:T40) were evaluated for differences by diagnosis and relation to PET Aβ positivity. Relationships between these measures and cerebral Aβ and tau on both regional and voxel‐wise basis were also evaluated. Results Lower Aβ T42:T40 was associated with diagnosis and PET Aβ positivity. Lower plasma Aβ T42:T40 ratios predicted cerebral Aβ positivity, both across the full sample and in CN only. Finally, lower plasma Aβ T42:T40 ratios were associated with increased cortical Aβ and tau in AD‐related regions on both regional and voxel‐wise analyses. Discussion Plasma Aβ measures may be useful biomarkers for predicting cerebral Aβ and tau. Additional studies in larger samples are warranted.